reproducible
Because the SomaScan Assay does not rely on polyclonal antibodies, which are variable, SomaScan
data achieves coefficients of variation much lower than industry standards. Additionally, it is the only platform
that can be seamlessly used for the entire biomarker research pipeline from discovery to development consistently over time.
